NL-OMON26336招募中不适用
The use of ACE2 receptor increasing medication at hospital admission andmortality rates in COVID-19 patiënts
nonen0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Clinical diagnosis of COVID-19
- •Intubation for mechanical respiratory support (including
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuriaThe primary aim of the study consists in testing the hypothesis that blockade of the RAS may decrease the risk of developing adverse effects in patients with benign IgAN.Such blockade would first achieved with unique pharmacological class then shifting to the association of the two classes as soon as ineffective blockade is documentedMedDRA version: 9.1Level: SOCClassification code 10038359Term: Renal and urinary disordersEUCTR2005-003885-40-ITAZIENDA OSPEDALIERA PROVINCIALE DI LECCO
已完成
4 期
Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure LoweringHypertensionJPRN-UMIN000002531Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine30
已完成
不适用
High-dose angiotensin II receptor blocker (ARB), olmesartan, monotherapy versus combination therapy of normal-dose olmesartan with selective aldosterone antagonist, selara, treatment on central blood pressure in patients with ischemic heart disease: a single-center, prospective, randomized, open-labes studyHypertensionJPRN-UMIN000010768Showa University Northern Yokohama Hospital.60
进行中（未招募）
1 期
Dexmedetomidine or clonidine infusion for prevention of delirium after open heart surgeryEUCTR2021-001645-12-NOOslo University Hospital900
已完成
4 期
Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitisonalcoholic steatohepatitisJPRN-C000000202Gunma Liver Study Group10